https://www.medicure.com/ 2026-03-06 daily 1.0 https://www.medicure.com/about 2026-03-18 daily 0.9 https://www.medicure.com/leadership 2022-07-10 daily 0.9 https://www.medicure.com/board-of-directors 2024-11-18 daily 0.9 https://www.medicure.com/our-history 2025-07-16 daily 0.9 https://www.medicure.com/mission-and-values 2021-12-13 daily 0.9 https://www.medicure.com/medicure-marks-its-25th-anniversary 2026-03-18 daily 0.9 https://www.medicure.com/people-and-culture 2025-06-20 daily 0.9 https://www.medicure.com/careers 2022-02-08 daily 0.9 https://www.medicure.com/corporate-compliance 2021-12-13 daily 0.9 https://www.medicure.com/state-compliance 2024-03-19 daily 0.9 https://www.medicure.com/perspectives/it-takes-guts-to-find-a-cure 2022-09-05 daily 0.9 https://www.medicure.com/perspectives/infusing-passion-into-my-desk-job 2022-09-05 daily 0.9 https://www.medicure.com/meet-our-vp-of-medical-and-business-affairs 2023-02-16 daily 0.9 https://www.medicure.com/meet-our-president-and-coo 2023-02-13 daily 0.9 https://www.medicure.com/meet-our-compliance-officer 2023-02-13 daily 0.9 https://www.medicure.com/corporate-giving/christmas-cheer-board-a-community-of-sharing-and-giving 2021-12-10 daily 0.9 https://www.medicure.com/corporate-giving/meda-creating-sustainable-business-solutions-to-poverty 2021-12-10 daily 0.9 https://www.medicure.com/willow-place 2024-01-03 daily 0.9 https://www.medicure.com/indigenous-education-award 2025-06-20 daily 0.9 https://www.medicure.com/habitat-for-humanity 2024-08-27 daily 0.9 https://www.medicure.com/fort-garry-womenand-x2019-s-resource-centre 2025-06-20 daily 0.9 https://www.medicure.com/interview-with-ceo-albert-friesen 2022-09-09 daily 0.9 https://www.medicure.com/p5p-for-pnpo-deficiency 2026-02-13 daily 0.9 https://www.medicure.com/about-pnpo 2026-02-11 daily 0.9 https://www.medicure.com/products 2024-09-16 daily 0.9 https://www.medicure.com/aggrastat 2024-02-06 daily 0.9 https://www.medicure.com/marley-drug 2026-02-13 daily 0.9 https://www.medicure.com/sodium-nitroprusside-injection 2023-09-22 daily 0.9 https://www.medicure.com/pipeline 2023-09-22 daily 0.9 https://www.medicure.com/drug-safety 2021-12-13 daily 0.9 https://www.medicure.com/medical-information 2021-12-13 daily 0.9 https://www.medicure.com/patient-information 2021-12-13 daily 0.9 https://www.medicure.com/tardive-dyskinesia 2023-05-04 daily 0.9 https://www.medicure.com/business-development 2021-12-13 daily 0.9 https://www.medicure.com/aggrastat/patents 2023-05-03 daily 0.9 https://www.medicure.com/zypitamag/patents 2023-06-07 daily 0.9 https://www.medicure.com/marley-drug/about 2022-08-16 daily 0.9 https://www.medicure.com/marley-drug/why-marley-drug 2025-07-14 daily 0.9 https://www.medicure.com/marley-drug/what-we-offer 2022-06-21 daily 0.9 https://www.medicure.com/news-and-media 2026-02-12 daily 0.9 https://www.medicure.com/news-and-media 2026-02-09 daily 0.9 https://www.medicure.com/press-releases 2023-02-10 daily 0.9 https://www.medicure.com/social-media 2021-12-13 daily 0.9 https://www.medicure.com/media 2025-01-22 daily 0.9 https://www.medicure.com/dr-friesen-sme 2025-01-29 daily 0.9 https://www.medicure.com/monica-amin-sme 2025-01-20 daily 0.9 https://www.medicure.com/neil-owens-sme 2025-01-21 daily 0.9 https://www.medicure.com/leanne-taylor-road-to-paris- 2024-09-03 daily 0.9 https://www.medicure.com/why-medicure-aquired-marley-drug 2024-08-13 daily 0.9 https://www.medicure.com/medicure-top-10 2024-08-13 daily 0.9 https://www.medicure.com/marley-drug-top-10 2024-08-13 daily 0.9 https://www.medicure.com/innovations 2024-08-13 daily 0.9 https://www.medicure.com/marley-drug-acquisition 2024-08-13 daily 0.9 https://www.medicure.com/neil-top-25 2024-08-13 daily 0.9 https://www.medicure.com/leanne-top-25 2024-08-13 daily 0.9 https://www.medicure.com/albert-friesen-bam-leadership-award 2024-08-13 daily 0.9 https://www.medicure.com/vanessa-dsn-award 2024-08-13 daily 0.9 https://www.medicure.com/reuben-pharmacy-award 2024-08-13 daily 0.9 https://www.medicure.com/best-place-to-work-award 2024-08-13 daily 0.9 https://www.medicure.com/rare-disease-day 2026-02-17 daily 0.9 https://www.medicure.com/investors 2025-11-19 daily 0.9 https://www.medicure.com/events 2022-07-22 daily 0.9 https://www.medicure.com/presentations-conference-calls 2025-11-19 daily 0.9 https://www.medicure.com/stock-information 2021-12-13 daily 0.9 https://www.medicure.com/annual-reports 2025-04-25 daily 0.9 https://www.medicure.com/quarterly-reports 2025-11-19 daily 0.9 https://www.medicure.com/corporate-governance 2021-12-13 daily 0.9 https://www.medicure.com/investor-contacts 2025-07-10 daily 0.9 https://www.medicure.com/contact-us 2023-04-27 daily 0.9 https://www.medicure.com/medicure-direct 2021-12-13 daily 0.9 https://www.medicure.com/medicure-direct/product-issues 2023-03-29 daily 0.9 https://www.medicure.com/medicure-direct/terms-and-conditions 2021-12-13 daily 0.9 https://www.medicure.com/studies/fabpro2012 2021-10-29 daily 0.9 https://www.medicure.com/studies/moroi2020 2021-10-29 daily 0.9 https://www.medicure.com/studies/realcad2018 2021-10-29 daily 0.9 https://www.medicure.com/studies/fabfast2020 2021-10-29 daily 0.9 https://www.medicure.com/covid-19-response 2021-12-08 daily 0.9 https://www.medicure.com/wcm-docs/freetext/medicure_privacy_policy_20211026143327.pdf 2021-10-26 daily 0.9 https://www.medicure.com/press-releases/medicure-international-and-iroko-cardio-sign-an-agreement-for-the-advancement-of-aggrastat-worldwide 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-executive-officer-change 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-grant-of-options-6 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-birmingham-debt-settlement 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-appointment-of-dawson-reimer-as-president-and-chief-operating-officer 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-appointment-of-new-cfo 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-fiscal-2011 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-graduation-to-tsx-venture-exchange 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-first-quarter-2012-financial-results 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-provides-update-on-tend-td-phase-ii-clinical-trial 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-second-quarter-2012-financial-results 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-aggrastat-clinical-trial-savi-pci 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-third-quarter-2012-financial-results 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-commencement-of-enrollment-in-savi-pci-trial-of-aggrastat 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-fiscal-2012 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-proposed-fifteen-to-one-share-consolidation 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-development-of-novel-aggrastat-formulation 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-intention-to-seek-expanded-aggrastat-label 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-first-quarter-financial-results-for-fiscal-2013 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-completes-share-consolidation 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-agreement-to-promote-aggrastat-in-the-commonwealth-of-puerto-rico 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-filing-of-snda-for-aggrastat-label-change 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-appoints-brent-fawkes-to-board-of-directors 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-second-quarter-financial-results-for-fiscal-2013 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/dr-albert-d-friesen-to-file-early-warning-report-2 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-third-quarter-financial-results-for-fiscal-2013 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-grant-of-options-5 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-fiscal-2013 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-approval-of-recommended-dosing-regimen-for-aggrastat 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-first-quarter-financial-results-for-fiscal-2014 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-second-quarter-financial-results-for-fiscal-2014 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-the-third-quarter-fiscal-2014 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-engages-knight-therapeutics-inc-to-provide-advisory-services 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-comments-on-recent-trading-activity 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-acquires-minority-position-in-pharmaceutical-manufacturer-apicore 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-grant-of-options-4 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-shares-for-debt-settlement 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-provides-update-on-tardoxal-and-tend-td-study 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-fiscal-2014 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-the-first-quarter-fiscal-2015 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/dr-albert-d-friesen-to-file-early-warning-report 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-change-in-fiscal-year-end-and-provides-one-time-guidance-on-quarterly-revenue 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-issuance-of-shares-under-previously-announced-shares-for-debt-settlement-2 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-shares-for-debt-settlements 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-provides-quarterly-revenue-on-a-calendar-basis-following-change-to-year-end 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-issuance-of-shares-under-previously-announced-shares-for-debt-settlement 2023-02-09 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-grant-of-options-3 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-the-seven-months-ended-december-31-2014 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-to-present-at-the-2015-bloom-burton-co-healthcare-conference 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-approval-of-expanded-dosing-time-for-aggrastat 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-q1-results-and-conference-call-dates-2 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-the-first-quarter-of-2015 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-35-million-bought-deal-private-placement 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-closes-bought-deal-private-placement-financing-for-gross-proceeds-of-4-025-000 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-grant-of-options-2 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-q2-results-and-conference-call-dates-2 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-second-quarter-2015-financial-results 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-filing-of-snda-for-new-aggrastat-indication 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-q3-results-and-conference-call-dates-2 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-third-quarter-2015-financial-results 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-grant-of-stock-options-2 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-pdufa-action-date-for-new-aggrastat-indication 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-anda-collaboration-with-apicore 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-preliminary-revenue-for-fiscal-2015 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-to-present-at-cantech-investment-conference 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/meta-analysis-of-aggrastat-tirofiban-hcl-presented-at-crt-2016-conference 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-to-announce-fiscal-year-2015-financial-results-on-march-30-2016 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-and-year-ended-december-31-2015 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-upcoming-conference-presentations 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-grant-of-options 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-to-announce-q1-2016-financial-results-on-may-11-2016 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-departure-of-president-and-chief-operating-officer 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-files-application-for-new-aggrastat-product-format 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-first-quarter-2016-financial-results 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-receives-response-letter-from-fda-on-aggrastat-snda-for-new-indication 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-to-announce-q2-2016-financial-results-on-august-10-2016 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-second-quarter-2016-financial-results 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/fda-approves-new-aggrastat-product-format 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-to-announce-q3-2016-financial-results-on-november-9-2016 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-third-quarter-2016-financial-results 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-exercises-option-to-acquire-majority-interest-in-apicore 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-to-hold-investor-call-on-november-21-2016 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-closes-acquisition-of-majority-interest-in-apicore 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-filing-of-anda-in-collaboration-with-apicore 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-provides-apicore-secured-loan-to-replace-knight-loan 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-fda-approval-for-apicores-generic-tetrabenazine 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-to-announce-fiscal-year-end-2016-financial-results-on-april-26-2017 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-and-year-ended-december-31-2016 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-q1-results-and-conference-call-dates 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-march-31-2017 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-provides-update-on-apicore-purchase-option 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-exercises-option-to-acquire-additional-interests-in-apicore 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-closes-acquisition-of-additional-interests-in-apicore 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-q2-results-and-conference-call-dates 2023-02-08 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-june-30-2017 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-sale-of-apicore-business 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-acquires-exclusive-license-to-sell-and-market-prexxartan-in-the-us-from-carmel-biosciences 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-q3-results-and-conference-call-dates 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-repayment-of-outstanding-debt 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-september-30-2017 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-acquires-exclusive-license-to-sell-and-market-branded-cardiovascular-drug-in-the-us 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-fda-approval-received-for-prexxartan 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-receipt-of-deferred-proceeds-from-apicore-sale 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/zydus-partners-with-medicure-to-launch-its-nda-product-zypitamag-pitavastatin-in-the-us 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-an-up-date-on-prexxartan-launch 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-further-up-date-on-prexxartan 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-to-announce-fiscal-year-end-2017-financial-results-on-april-30-2018 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-availability-of-zypitamag-pitavastatin-in-the-us 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-and-year-ended-december-31-2017 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-normal-course-issuer-bid-2 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-q1-2018-results-and-conference-call-dates 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-march-31-2018 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-q2-2018-results-and-conference-call-dates 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-fda-approval-of-acute-care-cardiovascular-drug-sodium-nitroprusside-injection 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-june-30-2018 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-q3-2018-results-and-conference-call-dates 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-files-patent-infringement-action-2 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-september-30-2018 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-agreement-to-market-reds-device-for-congestive-heart-failure-patients-in-the-united-states 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-provides-update-on-release-of-holdback-funds-from-apicore-sale 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-to-announce-fiscal-year-end-2018-financial-results-on-april-29-2019 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-and-year-ended-december-31-2018 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-appoints-ms-manon-harvey-to-its-board-of-directors 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-q1-2019-results-and-conference-call-dates 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-march-31-2019 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-renewal-of-its-normal-course-issuer-bid 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-appoinment-of-dr-neil-owens-as-president-and-chief-operating-officer 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-results-of-2019-annual-meeting-of-shareholders 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-q2-2019-results-and-conference-call-dates 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-june-30-2019 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-settlement-of-patent-infringement-action-2 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-launch-of-new-and-improved-reds-pro 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-acquisition-of-full-united-states-ownership-of-zypitamag 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-preferred-pricing-agreement-for-zypitamag-with-the-aids-drug-assistance-program-adap-crisis-task-force 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-smile-hf-study-demonstrates-use-of-reds-results-in-58-reduction-in-hospital-readmission-rate 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-intention-to-commence-substantial-issuer-bid 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-commencement-of-substantial-issuer-bid 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-q3-2019-results-and-conference-call-dates 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-september-30-2019 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-settlement-of-holdback-dispute-from-apicore-sale 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-files-patent-infringement-action 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-completion-of-enrollment-for-fabolus-faster-phase-4-clinical-trial-of-aggrastat-tirofiban-hydrochloride-injection-vs-kengreal-cangrelor-in-patients-undergoing-percutaneous-coronary-intervention-pci 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-preliminary-results-of-substantial-issuer-bid 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-the-completion-of-shortened-aggrastat-versus-integrilin-in-percutaneous-coronary-intervention-savi-pci-study 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-to-announce-fiscal-year-end-2019-financial-results-on-april-15-2020 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-and-year-ended-december-31-2019 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-q1-2020-results-and-conference-call-dates 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-march-31-2020 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-top-line-data-from-fabolus-faster-trial-with-aggrastat-will-be-presented-at-the-pcr-e-course-late-breaking-trial-sessions-june-27-2020 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-a-direct-to-patient-online-pharmacy-program-for-distribution-of-zypitamag-pitavastatin-tablets 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-normal-course-issuer-bid 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-positive-results-for-aggrastat-in-the-fabolus-faster-trial-and-publication-in-the-journal-circulation 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-q2-2020-results-and-conference-call-dates 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-june-30-2020 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-termination-of-redstm-pro-marketing-and-distribution-agreement 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-aggrastat-shows-promise-in-treating-thrombotic-complications-due-to-covid-19-in-early-clinical-reports 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-an-agreement-with-reliance-life-sciences-for-the-marketing-rights-of-a-cardiovascular-biosimilar 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-q3-2020-results-and-conference-call-dates 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-september-30-2020 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-settlement-of-patent-infringement-action 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-retains-investor-relations-firm-renmark-financial-communications-inc 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-enters-the-us-online-pharmacy-world-with-acquisition-of-marley-drug 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-pivotal-phase-3-trial-ind-filing-with-fda-for-treatment-of-seizures-associated-with-pyridox-am-ine-5-phosphate-oxidase-pnpo-deficiency 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-early-completion-of-enrollment-for-ispasm-a-phase-1-2a-exploratory-clinical-trial-of-aggrastat-tirofiban-hydrochloride-injection-vs-placebo-for-induced-suppression-of-platelets-activity-in-aneurysmal-subarachnoid-hemorrhage-managem 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-to-participate-in-renmarks-virtual-non-deal-roadshow-series-on-monday-february-8-2021 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-to-participate-in-renmarks-virtual-non-deal-roadshow-series-on-tuesday-february-23-2021 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-to-participate-in-renmarks-virtual-non-deal-roadshow-series-on-tuesday-march-9-2021 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-to-participate-in-renmarks-virtual-non-deal-roadshow-series-on-tuesday-march-30-2021 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-and-year-ended-december-31-2020 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-resignation-of-chief-financial-officer-and-succession-plan-2 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-2020-annual-and-q1-2021-results-and-conference-call-date 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-march-31-2021 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-appointment-of-david-gurvey-as-chief-financial-officer 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-grant-of-stock-options 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-the-second-quarter-ended-june-30-2021 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-that-the-shortened-aggrastat-versus-integrilin-in-percutaneous-coronary-intervention-savi-pci-study-has-met-its-primary-endpoint 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-september-30-2021 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-plans-to-launch-innovative-e-commerce-pharmacy-platform-offering-hundreds-of-medications-directly-to-millions-of-americans 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-launches-e-commerce-pharmacy-platform-marleydrugcom-through-its-subsidiary-marley-drug-pharmacy 2023-02-10 daily 0.5 https://www.medicure.com/press-releases/medicures-subsidiary-marley-drug-to-partner-with-rxspark-the-next-generation-in-pharmacy-discount-programs-to-be-its-sole-mail-order-pharmacy 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-resignation-of-chief-financial-officer-and-succession-plan 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-to-report-financial-results-for-year-ended-december-31-2021-on-april-28th-at-7-30-am-cst 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-and-year-ended-december-31-2021 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-march-31-2022-and-appointment-of-haaris-uddin-as-chief-financial-officer 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-results-of-2022-agm 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-to-present-financial-results-on-august-25-2022-call-at-8-30-am-et-for-quarter-ended-june-30-2022 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-june-30-2022 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-to-present-financial-results-on-november-25-2022-call-at-8-30-am-et-for-quarter-ended-september-30-2022 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-september-30-2022 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-resignation-of-board-member-and-grant-of-stock-options 2023-02-07 daily 0.5 https://www.medicure.com/press-releases/medicure-to-present-financial-results-on-april-10-2023-call-at-8-30-am-et-for-quarter-and-year-ended-december-31-2022 2023-04-05 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-and-year-ended-december-31-2022 2023-04-06 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-march-31-2023 2023-05-26 daily 0.5 https://www.medicure.com/press-releases/medicure-to-present-financial-results-on-july-31-2023-call-at-8-30-am-et-for-quarter-ended-june-30-2023 2023-07-25 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-june-30-2023 2023-07-28 daily 0.5 https://www.medicure.com/press-releases/medicure-reiterates-its-commitment-to-providing-exceptional-access-to-its-branded-pitavastatin-zypitamag-to-people-living-with-hiv 2023-08-30 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-september-30-2023 2023-11-21 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-fda-provides-complete-approval-to-enroll-patients-in-its-pivotal-phase-3-trial-for-treatment-of-rare-pediatric-disease 2023-11-23 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-new-partnership-through-its-marley-drug-subsidiary-to-provide-brenzavvy-as-an-affordable-medication-for-americans-with-type-2-diabetes 2023-12-05 daily 0.5 https://www.medicure.com/press-releases/medicure-to-present-financial-results-on-april-9-2024-call-at-8-30-am-et-for-quarter-and-year-ended-december-31-2023 2024-04-04 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-and-year-ended-december-31-2023 2024-04-08 daily 0.5 https://www.medicure.com/press-releases/medicure-receives-us-fda-fast-track-designation-for-mc-1-for-pnpo-deficiency 2024-04-23 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-march-31-2024-and-annual-general-meeting-director-election-results 2024-05-28 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-signing-of-asset-purchase-agreement-with-canam-bioresearch-inc-for-acquisition-of-intellectual-property 2024-06-24 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-june-30-2024 2024-08-14 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-closing-of-asset-purchase-agreement-with-canam-bioresearch-for-acquisition-of-intellectual-property 2024-08-14 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-positive-settlement-of-product-development-and-supply-contracts 2024-10-24 daily 0.5 https://www.medicure.com/press-releases/medicure-to-present-financial-results-on-november-26-2024-call-at-8-30-am-et-for-quarter-ended-september-30-2024-and-announces-resignation-of-board-member 2024-11-18 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-september-30-2024 2024-11-25 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-expansion-of-its-pharmacy-business-through-signing-of-a-purchase-agreement-for-the-acquisition-of-gateway-medical-pharmacy 2025-02-18 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-closing-of-purchase-agreement-for-the-acquisition-of-gateway-medical-pharmacy 2025-04-10 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-further-expansion-of-its-pharmacy-business-through-signing-of-a-purchase-agreement-for-the-acquisition-of-west-olympia-pharmacy 2025-04-11 daily 0.5 https://www.medicure.com/press-releases/medicure-to-present-financial-results-on-april-29-2025-call-at-8-30-am-et-for-quarter-and-year-ended-december-31-2024 2025-04-22 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-and-year-ended-december-31-2024 2025-04-25 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-march-31-2025-and-annual-general-meeting-director-election-results 2025-05-21 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-closing-of-purchase-agreement-for-the-acquisition-of-west-olympia-pharmacy 2025-06-17 daily 0.5 https://www.medicure.com/press-releases/medicure-to-present-financial-results-on-august-21-2025-call-at-8-30-am-et-for-quarter-ended-june-30-2025 2025-08-18 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-june-30-2025 2025-08-20 daily 0.5 https://www.medicure.com/press-releases/medicure-announces-update-on-enrollment-in-its-mend-pnpo-phase-3-clinical-trial-and-presentation-of-the-trial-design-and-baseline-data-at-the-2025-child-neurology-society-conference 2025-09-23 daily 0.5 https://www.medicure.com/press-releases/medicure-to-present-financial-results-on-november-20-2025-call-at-8-30-am-et-for-quarter-ended-september-30-2025 2025-11-13 daily 0.5 https://www.medicure.com/press-releases/medicure-reports-financial-results-for-quarter-ended-september-30-2025 2025-11-19 daily 0.5